There are 2789 resources available
1327P - Impact of bone targeted agents (BTA) in advanced non-small cell lung cancer (aNSCLC) patients (pts) with high bone tumor burden (HBTB) treated with PD(L)1 inhibitors (ICIs)
Presenter: Sara Manglaviti
Session: ePoster Display
1388P - Efficacy of second line immunotherapy in advanced upper gastrointestinal tract malignancies: A pooled analysis of randomized clinical trials
Presenter: Panagiotis Ntellas
Session: ePoster Display
1391P - Clinical progress in inoperable or recurrent advanced gastric cancer treatment from 1,004 single institute experiences between 2007 and 2018
Presenter: Izuma Nakayama
Session: ePoster Display
1331P - Open-label phase I/II study evaluating the tolerability and anti-tumor activity of selinexor (SEL) and docetaxel (DTX) in non-small cell lung cancer (NSCLC)
Presenter: Alona Zer
Session: ePoster Display
1332P - A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)
Presenter: Susumu Takeuchi
Session: ePoster Display
1333P - Dose and schedule modifications of carboplatin plus nab-paclitaxel for elderly patients with squamous non-small cell lung cancer from the CAPITAL study
Presenter: Go Saito
Session: ePoster Display